Back to discover
Disease

Leishmaniasis

Late-stage therapeutic developmentEmerging researchRising momentum
5
Publications
19
Clinical trials
1
Related conditions
2024
Latest publication
Latest activity
beta

Recent clinical, regulatory, research and industry developments relating to this disease.

What's happening now

An analyst briefing on current research, clinical, regulatory and industry activity surrounding this disease.

Executive briefingUpdating summary…Momentum: Low
Key developments
  • 1 clinical trial expected to report results, the earliest in Q4 2029.

Clinical trials

11 sponsors · 1 new · 0 completed in the last 12 months (net +1)

The current development programme across all trial phases.

Clinical programme
19
All trials
6
Active
10
Late-stage
6
Completed
Late-stage studies
Recruiting
Recently completed

Research activity

5 papers

Key research shaping understanding of this disease, combining the latest publications with the most influential evidence.

Publications over time
20012024
Major themes8
  • Leishmaniasis2
  • Aedes1
  • Anopheles1
  • Chagas Disease1
  • COVID-191
  • Culex1
  • Insecticides1
  • Malaria1
Leading journals5
  • BMJ global health1
  • Medical and veterinary entomology1
  • Nature reviews. Microbiology1
  • Parasites & vectors1
  • Transactions of the Royal Society of Tropical Medicine and Hygiene1
Leading researchers8
  • Awotiwon A1
  • Babayan L1
  • Báfica ACMF1
  • Balaska S1
  • Bichaud L1
  • Charrel RN1
  • Cornick RV1
  • da Silveira JPM1
Affiliations (unnormalised)6
  • Clinic Management Coordination1
  • Institute of Molecular Biology and Biotechnology1
  • National Center for Disease Control and Prevention1
  • Pesticide Science Laboratory1
  • School of Life Course & Population Sciences1
  • University of Cape Town1

Related conditions

1 match

Diseases frequently studied alongside this one. Number shows shared papers.

Disease profile

A grounded synthesis of the condition — overview, causes, mechanism, risk factors and current standard of care.

Overview

Leishmaniasis is an infectious disease caused by protozoa of the genus Leishmania. It includes four major clinical forms: cutaneous, diffuse cutaneous, mucocutaneous, and visceral leishmaniasis.

Causes

Leishmaniasis is caused by infection with species of the protozoan genus Leishmania. Transmission is associated with phlebotomine sandflies, which are proven or suspected vectors for human leishmaniases.

Pathophysiology

The disease results from infection by Leishmania protozoa, with clinical expression varying by species and form of disease. The literature grounding provided here supports vector-borne transmission and the existence of distinct cutaneous and visceral disease entities, but does not provide further mechanistic detail.

Risk factors

Risk is increased by environmental and social conditions that favor transmission, including inadequate housing, drinking-water, and sanitation in rapidly growing urban areas. Human migration, deforestation, urbanization, increased sandfly breeding sites and blood sources, and interruption of vector control activities are also described as contributors to spread.

Current standard of care

Drug therapy is a standard treatment modality for leishmaniasis. The supplied grounding supports treatment at the drug-class or modality level only and does not specify particular agents or regimens.

AI-generated summary grounded in MeSH and 3 peer-reviewed sources. Informational only — not medical advice. Generated 2026-07-07.

Reference

Authoritative identity, definition & identifiers.

Defined in MeSH

A disease caused by any of a number of species of protozoa in the genus LEISHMANIA. There are four major clinical types of this infection: cutaneous (Old and New World) (LEISHMANIASIS, CUTANEOUS), diffuse cutaneous (LEISHMANIASIS, DIFFUSE CUTANEOUS), mucocutaneous (LEISHMANIASIS, MUCOCUTANEOUS), and visceral (LEISHMANIASIS, VISCERAL).

References & data sources
  • Disease identity & definition — NLM Medical Subject Headings (MeSH), public domain
  • Clinical trials — ClinicalTrials.gov (U.S. National Library of Medicine)
  • Research activity — Europe PMC (EMBL-EBI) + OpenAlex-derived paper links
  • Related entities are derived from literature co-mention (studied together) — associative, not causal.